Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

4.80
+0.07001.48%
Post-market: 4.880.0800+1.67%16:56 EDT
Volume:238.95K
Turnover:1.18M
Market Cap:8.70M
PE:-0.21
High:5.17
Open:5.17
Low:4.61
Close:4.73
Loading ...

Cellectar Biosciences Executives Make Bold Stock Purchases!

TIPRANKS
·
04 Jul

CEO James V. Caruso Reports Acquisition of Cellectar BioSciences Inc. Common Shares

Reuters
·
03 Jul

Cellectar BioSciences COO Jarrod Longcor Reports Acquisition of Common Shares

Reuters
·
03 Jul

Cellectar Biosciences Closes $6.9 Million Public Offering

MT Newswires Live
·
03 Jul

Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option

GlobeNewswire
·
03 Jul

Top Midday Decliners

MT Newswires Live
·
02 Jul

Cellectar Biosciences Shares Drop After $6M Public Offering Prices

Dow Jones
·
01 Jul

Cellectar prices 865,000 units at $5.00 in underwritten public offering

TIPRANKS
·
01 Jul

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

THOMSON REUTERS
·
01 Jul

Cellectar Biosciences Plans Phase 1 Cancer Studies

TIPRANKS
·
26 Jun

Cellectar Biosciences files to sell 755,667 Class A Units

TIPRANKS
·
26 Jun

Cellectar Biosciences, Nusano enter into multi-isotope supply agreement

TIPRANKS
·
26 Jun

Cellectar Biosciences and U.S.-Based Nusano Enter Into Multi-Isotope Supply Agreement

THOMSON REUTERS
·
26 Jun

Cellectar BioSciences Announces One-for-Thirty Reverse Stock Split

Reuters
·
26 Jun

BRIEF-Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer

Reuters
·
24 Jun

Cellectar Biosciences Submits Phase 1B Clinical Trial Protocol to US Food and Drug Administration for Clr 125 to Treat Triple-Negative Breast Cancer (Tnbc)

THOMSON REUTERS
·
24 Jun

Cellectar Biosciences Reports 1-for-30 Reverse Stock Split, Effective June 24

MT Newswires Live
·
19 Jun

Cellectar Biosciences announces 1-for-30 reverse stock split

TIPRANKS
·
19 Jun

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split

THOMSON REUTERS
·
19 Jun

Cellectar BioSciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun